Peer-reviewed veterinary case report
Ablation of microRNA-155 and neuroinflammation in a mouse model of CLN1-disease.
- Journal:
- Biochemical and biophysical research communications
- Year:
- 2021
- Authors:
- Sadhukhan, Tamal et al.
- Affiliation:
- Section on Developmental Genetics · United States
- Species:
- rodent
Abstract
Infantile neuronal ceroid lipofuscinosis (INCL), also known as CLN1-disease, is a devastating neurodegenerative lysosomal storage disorder (LSD), caused by inactivating mutations in the CLN1 gene. The Cln1mice, which mimic INCL, manifest progressive neuroinflammation contributing to neurodegeneration. However, the underlying mechanism of neuroinflammation in INCL and in Cln1mice has remained elusive. Previously, it has been reported that microRNA-155 (miR-155) regulates inflammation and miR profiling in Cln1mouse brain showed that the level of miR-155 was upregulated. Thus, we sought to determine whether ablation of miR-155 in Cln1mice may suppress neuroinflammation in these mice. Towards this goal, we generated Cln1/miR-155double-knockout mice and evaluated the inflammatory signatures in the brain. We found that the brains of double-KO mice manifest progressive neuroinflammatory changes virtually identical to those found in Cln1mice. We conclude that ablation of miR-155 in Cln1mice does not alter the neuroinflammatory trajectory in INCL mouse model.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/34325129/